|
Cardiovascular Pharmacology
Citations 321-330 of 1154 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Angiotensin-Converting Enzyme Inhibitors. A New Mechanism of Action
- Hongmei Peng, Oscar A. Carretero, Nikola Vuljaj, Tang-Dong Liao, Apurva Motivala, Edward L. Peterson, and Nour-Eddine Rhaleb
Circulation published October 10, 2005, doi:10.1161/CIRCULATIONAHA.104.528695
[Abstract]
- Editorials
Recurrent Pericarditis: Recent Advances and Remaining Questions
- Ralph Shabetai
Circulation 2005;112:1921-1923, doi:10.1161/CIRCULATIONAHA.105.569244
[Full text]
- Pericardial Disease
Colchicine in Addition to Conventional Therapy for Acute Pericarditis: Results of the COlchicine for acute PEricarditis (COPE) Trial
- Massimo Imazio, Marco Bobbio, Enrico Cecchi, Daniela Demarie, Brunella Demichelis, Franco Pomari, Mauro Moratti, Gianni Gaschino, Massimo Giammaria, Aldo Ghisio, Riccardo Belli, and Rita Trinchero
Circulation 2005;112:2012-2016, doi:10.1161/CIRCULATIONAHA.105.542738
[Abstract]
[Full text]
- Clinician Update
Diuretics for Hypertension
- Lawrence R. Krakoff
Circulation 2005;112:e127-129e, doi:10.1161/CIRCULATIONAHA.105.570192
[Full text]
- Editorials
Protecting the Heart Against Arrhythmias: Potassium Current Physiology and Repolarization Reserve
- Dan M. Roden and Tao Yang
Circulation 2005;112:1376-1378, doi:10.1161/CIRCULATIONAHA.105.562777
[Full text]
- Articles
Effect on Survival and Hospitalization of Initiating Treatment for Chronic Heart Failure With Bisoprolol Followed by Enalapril, as Compared With the Opposite Sequence. Results of the Randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III
- Ronnie Willenheimer, Dirk J. van Veldhuisen, Bernard Silke, Erland Erdmann, Ferenc Follath, Henry Krum, Piotr Ponikowski, Allan Skene, Louis van de Ven, Patricia Verkenne, Philippe Lechat on behalf of the CIBIS III Investigators
Circulation published September 4, 2005, doi:10.1161/CIRCULATIONAHA.105.582320
[Abstract]
- Myocardial Protection and Vascular Biology
Atorvastatin Inhibits Hypercholesterolemia-Induced Calcification in the Aortic Valves via the Lrp5 Receptor Pathway
- Nalini M. Rajamannan, Malayannan Subramaniam, Frank Caira, Stuart R. Stock, and Thomas C. Spelsberg
Circulation 2005;112:I-229-234I-, doi:10.1161/01.CIRCULATIONAHA.104.524306
[Abstract]
[Full text]
- Coronary Heart Disease
Impact of a Single Intravenous Administration of Nicorandil Before Reperfusion in Patients With ST-Segment–Elevation Myocardial Infarction
- Hideki Ishii, Satoshi Ichimiya, Masaaki Kanashiro, Tetsuya Amano, Kenji Imai, Toyoaki Murohara, and Tatsuaki Matsubara
Circulation 2005;112:1284-1288; published online before print as doi:10.1161/CIRCULATIONAHA.104.530329
[Abstract]
[Full text]
- Health Services and Outcomes Research
Impact of the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22/Reversal of Atherosclerosis With Aggressive Lipid Lowering Trials on Trends in Intensive Versus Moderate Statin Therapy in Ontario, Canada
- Peter C. Austin and Muhammad M. Mamdani
Circulation 2005;112:1296-1300; published online before print as doi:10.1161/CIRCULATIONAHA.104.531582
[Abstract]
[Full text]
- Vascular Medicine
Endothelial ß3-Adrenoreceptors Mediate Nitric Oxide–Dependent Vasorelaxation of Coronary Microvessels in Response to the Third-Generation ß-Blocker Nebivolol
- Chantal Dessy, Julie Saliez, Philippe Ghisdal, Géraldine Daneau, Irina I. Lobysheva, Françoise Frérart, Catharina Belge, Karima Jnaoui, Philippe Noirhomme, Olivier Feron, and Jean-Luc Balligand
Circulation 2005;112:1198-1205, doi:10.1161/CIRCULATIONAHA.104.532960
[Abstract]
[Full text]
|
|
